NIMC
NAGE

Nierenberg Investment Management Company’s Niagen Bioscience NAGE Stock Holding History

Nierenberg Investment Management Company’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,555
Closed -$79.7K – 58
2025
Q1 		$79.7K Hold
11,555
– – 0.04% 49
2024
Q4 		$61.3K Hold
11,555
– – 0.03% 46
2024
Q3 		$42.2K Hold
11,555
– – 0.02% 48
2024
Q2 		$31.5K Buy
+11,555
New +$38.7K 0.02% 50

Other funds holding NAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Nierenberg Investment Management Company's NAGE Position: Q2 2025 in Review

Nierenberg Investment Management Company sold out of Niagen Bioscience (NAGE) in Q2 2025, closing a stake of 11,555 shares — an estimated $79.7K sold.

Nierenberg Investment Management Company first reported a position in NAGE in Q2 2024 and held it in 4 quarters. The position peaked at $79.7K in Q1 2025. 155 funds tracked by Wall St. Rank hold NAGE as of Q2 2025.

  • Nierenberg Investment Management Company reported no remaining Niagen Bioscience position as of Q2 2025 after selling out during the quarter.
  • Nierenberg Investment Management Company sold 11,555 Niagen Bioscience shares in Q2 2025, an estimated $79.7K.
  • Nierenberg Investment Management Company first reported a position in Niagen Bioscience in Q2 2024 and held it in 4 quarters.
  • Nierenberg Investment Management Company's Niagen Bioscience position peaked at $79.7K in Q1 2025.
  • 155 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2025.

Based on Nierenberg Investment Management Company's 13F filing for Q2 2025, filed 11 Aug 2025.